Conduit Pharmaceuticals Inc. (CDT)
NASDAQ: CDT · IEX Real-Time Price · USD
0.238
-0.022 (-8.56%)
At close: Jul 19, 2024, 4:00 PM
0.235
-0.003 (-1.30%)
Pre-market: Jul 22, 2024, 7:28 AM EDT
Conduit Pharmaceuticals Market Cap
Conduit Pharmaceuticals has a market cap or net worth of $17.58 million as of July 22, 2024. Its market cap has decreased by -73.76% in one year.
Market Cap
17.58M
Enterprise Value
17.03M
1-Year Change
-73.76%
Ranking
Category
Stock Price
$0.24
Market Cap Chart
Since February 3, 2022, Conduit Pharmaceuticals's market cap has decreased from $151.10M to $17.58M, a decrease of -88.37%. That is a compound annual growth rate of -58.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 17.60M | -94.76% |
| Dec 29, 2023 | 335.90M | 89.56% |
| Dec 30, 2022 | 177.20M | 17.27% |
| Feb 3, 2022 | 151.10M | - |
View and export this data all the way back to 2022.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GlycoMimetics | 18.33M |
| Indaptus Therapeutics | 18.19M |
| Synlogic | 18.15M |
| Aeterna Zentaris | 17.91M |
| Biotricity | 17.70M |
| Aptorum Group | 17.26M |
| Lyra Therapeutics | 17.07M |
| VBI Vaccines | 17.06M |